Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

BuTrans price, strengths & recalls

Brand of buprenorphine (generic)

Pharmacies pay $83,752.68 for 672 hs of BuTrans 0.015 mg/hr (168 hr) patch this week, and from $32,828.47 to $88,083.11 across its 5 priced strengths and forms. The generic, buprenorphine, costs pharmacies from $8.62. It has 27 recalls on record, none ongoing. Its official label last changed on May 13, 2026.

Brand
Pharmacies pay$83,752.68for 672 hs of 0.015 mg/hr (168 hr) patchNo change in 4 weeks
Fair cash price
$96,326.08
Strengths
5
Makers
1
Updated
Nov 11

BuTrans price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.005 mg/hr (168 hr) patch Brand$48.85$32,828.47 / 672 hsNo change-0.2%
0.0075 mg/hr (168 hr) patch Brand$68.73$46,184.18 / 672 hs-0.1%No change
0.01 mg/hr (168 hr) patch Brand$73.55$49,428.56 / 672 hs-0.1%-0.3%
0.015 mg/hr (168 hr) patch Brand$124.63$83,752.68 / 672 hsNo change-0.2%
0.02 mg/hr (168 hr) patch Brand$131.08$88,083.11 / 672 hsNo change-0.1%

BuTrans vs generic buprenorphine

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
0.005 mg/hr (168 hr) patch$32,828.47$16,185.102x
0.0075 mg/hr (168 hr) patch$46,184.18$25,661.581.8x
0.01 mg/hr (168 hr) patch$49,428.56$22,794.222.2x
0.015 mg/hr (168 hr) patch$83,752.68$33,942.872.5x
0.02 mg/hr (168 hr) patch$88,083.11$39,564.982.2x
GenericBuprenorphine prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
6 ongoing recalls27 recalls on record

Recalls

Showing the 6 most relevant of 27 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for butrans? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMay 13, 2026
Version32 of 25
EffectiveMay 1, 2026
Read the label

These highlights do not include all the information needed to use BUTRANS® safely and effectively. See full prescribing information for BUTRANS. BUTRANS® (buprenorphine) transdermal system, CIIIInitial U.S. Approval: 1981

This drug has a boxed warning

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF BUTRANS

Addiction, Abuse, and Misuse

Because the use of BUTRANS® exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)].

Life-Threatening Respiratory Depression

Serious, life-threatening, or fatal respiratory depression may occur with use of BUTRANS, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of BUTRANS are essential. Misuse or abuse of BUTRANS by chewing, swallowing, snorting or injecting buprenorphine extracted from the transdermal system will result in the uncontrolled delivery of buprenorphine and pose a significant risk of overdose and death [see Warnings and Precautions (5.2)].

Accidental Exposure

Accidental exposure of even one dose of BUTRANS, especially in children, can result in a fatal overdose of buprenorphine [see Warnings and Precautions (5.2)].

Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of BUTRANS and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.3), Drug Interactions (7)].

Neonatal Opioid Withdrawal Syndrome (NOWS)

Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery [see Warnings and Precautions (5.4)].

Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)

Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription [see Warnings and Precautions (5.5)].

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF BUTRANS

See full prescribing information for complete boxed warning.

BUTRANS exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient's risk before prescribing and reassess regularly for these behaviors and conditions. (5.1, 10)

Serious, life-threatening or fatal respiratory depression may occur, especially upon initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of BUTRANS are essential. Instruct patients on proper administration of BUTRANS to reduce the risk. (2.1, 5.2)

Accidental exposure to BUTRANS, especially in children, can result in fatal overdose of buprenorphine. (5.2)

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate. (5.3, 7)

Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery. (5.4)

Healthcare providers are strongly encouraged to complete a REMS- compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription. (5.5)

Recent major changes (as listed on the label)

Boxed Warning | 12/2025 |

Indications and Usage (1) | 12/2025 |

Dosage and Administration (2.2, 2.3, 2.5) | 12/2025 |

Warnings and Precautions (5.1, 5.2, 5.3 5.15, 5.19) | 12/2025 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021306 · Knoa Pharma
First approved
June 30, 2010 (16 years ago)
Latest approved change
June 18, 2026
Approved label
PDF, Jan 6, 2026
Generic makers
17 approved generic applications on the market

BuTrans questions

How much does butrans cost without insurance?

Pharmacies pay about $83,752.68 for 672 hs of butrans 0.015 mg/hr (168 hr) patch ($124.63 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $96,326.08. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for BuTrans?

Yes: buprenorphine. Pharmacies pay from $8.62 for it. Compare buprenorphine prices.

Is butrans in shortage?

No shortage is reported for butrans right now. We check the national shortage list every day.

Has butrans been recalled?

27 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the butrans label last change?

The official label was last updated on May 13, 2026 (version 32). See what changed.

Talk about butrans

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.